Southampton scientists develop new leukaemia cancer vaccine
A new cancer treatment which strengthens a patient’s immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK.
A new cancer treatment which strengthens a patient’s immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK.
IBM to help Sankara Nethralaya manage IT infra IBM is partnering Sankara Nethralaya, a speciality institution for ophthalmic care in […]
Advanced Techno-care with Quality MedcareMedcare Hospital, a new 90,000 sq feet multi-specialty hospital in the heart of New Dubai, will […]
Despite being one of the most developed states in the country, 93 per cent of hospital beds in Maharashtra are in urban areas, claimed an advocacy group which released a survey on health inequities recently.
Sindh makes rapid progress in telemedicinePakistan's Sindh region will set up telemedicine services all its 23 districts very soon. According […]
Madhya Pradesh commences e-healthcareNeonatal care through videoconfere-ncing is finally here. Sagar district in Madhya Pradesh, India has achieved that distinction. […]
The advanced technology and accessible treatment has made the once dreaded disease curable today.
A scanning fibre endoscope can be fitted into a casing usually used for covering medicines, and which is small enough to be swallowed. The devices records 15 colour images per second with a resolution of more than 500 lines per inch.
Virtual-reality surgery in a box
It’s common knowledge that to carry out genetic tests, one would need expensive, state-of-the-art laboratory. But that might soon change thanks to a group of Canadian scientists who’ve developed a “lab-on-a-chip” device to conduct these tests. What is interesting about the device is that it’s supposed to be portable, inexpensive, and efficient.
High doses of folic acid (vitamin B9) can lead to pregnancy problems, says a study from the McGill University.
The work led by Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine poses significant and immediate implications for neurobiology and the treatment of schizophrenia.
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.